Tongjitang Chinese Medicines Co. (ADR) (NYSE:TCM)

CAPS Rating: 3 out of 5

A vertically integrated and profitable specialty pharmaceutical company focusing on the development, manufacturing and marketing of modernized traditional Chinese medicine.

Recs

0
Player Avatar argaz (< 20) Submitted: 9/12/2008 5:28:17 PM : Outperform Start Price: $3.30 TCM Score: +22.48

no brainer

Featured Broker Partners


Advertisement